|
PIAS2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.33066907387547E-16 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62458935193399E-12 |
| Normal-vs-Stage2 |
2.66270006044067E-10 |
| Normal-vs-Stage3 |
3.50169999996375E-07 |
| Normal-vs-Stage4 |
5.11329999453025E-08 |
| Stage1-vs-Stage2 |
8.950000E-01 |
| Stage1-vs-Stage3 |
8.513400E-01 |
| Stage1-vs-Stage4 |
7.839000E-01 |
| Stage2-vs-Stage3 |
9.716000E-01 |
| Stage2-vs-Stage4 |
6.767600E-01 |
| Stage3-vs-Stage4 |
7.338400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.33066907387547E-16 |
| Normal-vs-AfricanAmerican |
1.17309495450968E-11 |
| Normal-vs-Asian |
4.77129999953974E-08 |
| Caucasian-vs-AfricanAmerican |
8.896200E-01 |
| Caucasian-vs-Asian |
4.568000E-01 |
| AfricanAmerican-vs-Asian |
4.745000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
6.63569998948788E-09 |
| Male-vs-Female |
2.319500E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.74850000040006E-07 |
| Normal-vs-Extreme_Weight |
<1E-12 |
| Normal-vs-Obese |
1.62669877568078E-12 |
| Normal-vs-Extreme_Obese |
8.023000E-04 |
| Normal_Weight-vs-Extreme_Weight |
1.007970E-01 |
| Normal_Weight-vs-Obese |
3.397800E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.123600E-01 |
| Extreme_Weight-vs-Obese |
3.732000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.685200E-01 |
| Obese-vs-Extreme_Obese |
8.439000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.08859621106694E-11 |
| Normal-vs-Age(41-60Yrs) |
1.67044156285101E-12 |
| Normal-vs-Age(61-80Yrs) |
<1E-12 |
| Normal-vs-Age(81-100Yrs) |
2.86137780136642E-12 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.444200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.945400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.372600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.750010E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.115000E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.876000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62436730732907E-12 |
| Normal-VS-Type2 PRCC |
1.07900000045902E-09 |
| Normal-VS-KIRP CIMP |
4.33389999998646E-07 |
| Normal-VS-Unclassified PRCC |
1.97889999942191E-08 |
| Type1 PRCC-VS-Type2 PRCC |
1.794370E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.365000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.012000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.188800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.359200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.774000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.62825308791525E-12 |
| Normal-vs-N1 |
3.48554518581068E-12 |
| Normal-vs-N2 |
1.043560E-04 |
| N0-vs-N1 |
9.670400E-01 |
| N0-vs-N2 |
9.655200E-01 |
| N1-vs-N2 |
9.474000E-01 |
|
|
